Expansion of IMBRUVICA® (ibrutinib) Label in the U.S.

Expansion of IMBRUVICA® (ibrutinib) Label in the U.S.

U.S. Food and Drug Administration (FDA) Approves a Label Expansion for IMBRUVICA® (ibrutinib)  On February 26th, Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics LLC, an AbbVie Company, announced that the U.S. Food and Drug...
The 2024 European WM Patient Forum

The 2024 European WM Patient Forum

By Hannah Syed, IWMF Global Partner Engagement Consultant IWMF collaborated with WMUK to host the second European WM Patient Forum on Saturday, 21 September 2024, in London, UK. The event brought together patients, carers, healthcare professionals, and researchers...
Professional Education: Advancing the IWMF Mission

Professional Education: Advancing the IWMF Mission

By Debra Entin, MS, RN, CPNPIWMF Consultant, Professional Education What is “professional education? Professional education at the International Waldenstrom’s Macroglobulinemia Foundation (IWMF) refers to educational programming targeted to healthcare professionals...
IWWM-12 Accelerates the Cure

IWWM-12 Accelerates the Cure

By Carl Harrington, IWMF Trustee, Chair Emeritus, and Vice Chair, Fundraising, and Jennifer Reilly, Medical Writer for Scientific Education Support (SES) Carl Harrington and Jennifer Reilly’s article “IWWM-12 Accelerates the Cure” shares the...
QIGONG FOR MENTAL HEALTH with Donna DeLuca

QIGONG FOR MENTAL HEALTH with Donna DeLuca

Thursday, Jan 30, 1-2:30 pm ET Cancer patients face exceptional psychological stresses. Medical situations can generate fear and sadness, anxiety, and depression. Medications and/or treatments can exacerbate emotional states. On top of that, they may face ongoing...
Make YOUR Voice Heard with the WM-VOICE Study

Make YOUR Voice Heard with the WM-VOICE Study

WM-VOICE study: Patient preferences on treatment options for Waldenström macroglobulinemia: An international discrete choice experiment. Study details: The WM-VOICE study is scientific research about Waldenström macroglobulinemia (WM). The study focuses on what...
Waldenström Finland Summer Summit 2024 – Helsinki

Waldenström Finland Summer Summit 2024 – Helsinki

Waldenström Finland Summer Summit 2024 – Helsinki By Jukka Sneck, Waldenström Finland From IWMF Torch October 2024 We had our annual face-to-face meeting on Saturday, August 24. The meeting took the whole day. Our association was founded five years ago, and this was...
IWMF Commits To Largest Research Package Since Inception!

IWMF Commits To Largest Research Package Since Inception!

IWMF Commits to Largest Research Package Since Inception! From IWMF Torch, October 2024 IWMF is making outstanding progress in the search for a cure. “Once we do a better job at shutting down the signaling of that mutated MYD88 gene, we will find that cure,” says Dr....